AURKA and hepatocellular carcinoma: Development of circRNA vaccines in HCC is a very promising area, and studies of gene expression in HCC tumors have already revealed new potential antigens such as AURKA (Aurora Kinase A) (92) and neoantigens (74) that could be considered for the design of novel circRNA vaccines.